This Article Full Text Full Text (PDF) All Versions of this Article: 44/1/48    most recent 01.HYP.0000132556.91792.6av1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Okin, P. M. Search for Related Content PubMed PubMed Citation Articles by Okin, P. M. Related Collections Hypertrophy Electrocardiology Clinical Studies

(Hypertension. 2004;44:48.)
© 2004 American Heart Association, Inc.

Scientific Contributions

Electrocardiographic Strain Pattern and Prediction of Cardiovascular Morbidity and Mortality in Hypertensive Patients

Peter M. Okin; Richard B. Devereux; Markku S. Nieminen; Sverker Jern; Lasse Oikarinen; Matti Viitasalo; Lauri Toivonen; Sverre E. Kjeldsen; Stevo Julius; Steven Snapinn; Björn Dahlöf for the LIFE Study Investigators

From the Greenberg Division of Cardiology (P.M.O., R.B.D.), Weill Medical College of Cornell University, New York, NY; the Division of Cardiology (M.S.N., L.O., M.V., L.T.), Department of Medicine, Helsinki University Central Hospital, Finland; Sahlgrenska University Hospital/Östra (S.J., B.D.), Göteborg, Sweden; Ullevål University Hospital (S.E.K.), Oslo, Norway; University of Michigan Medical Center (S.J.), Ann Arbor; and Merck Research Laboratories (S.S.), West Point, Pa.

Correspondence to Peter M. Okin, MD, Weill Medical College of Cornell University, 525 East 68th St, New York, NY 10021. E-mail pokin{at}mail.med.cornell.edu

The ECG strain pattern of lateral ST depression and T-wave inversion is a marker for left ventricular hypertrophy (LVH) and adverse prognosis in population studies. However, whether ECG strain is an independent predictor of cardiovascular (CV) morbidity and mortality in the setting of aggressive antihypertensive therapy is unclear. ECGs were examined at study baseline in 8854 hypertensive patients with ECG LVH who were treated in a blinded manner with atenolol- or losartan-based regimens. Strain was defined by the presence of a downsloping convex ST segment with an inverted asymmetrical T wave opposite to the QRS axis in leads V₅ and/or V₆ and was present in 971 patients (11.0%). The Losartan Intervention For Endpoint reduction in hypertension (LIFE) study composite end point of CV death or nonfatal myocardial infarction or stroke occurred in 1035 patients (11.7%). In Cox analyses adjusting only for treatment effect, ECG strain was a significant predictor of CV death (hazard ratio [HR] 2.26, 95% confidence interval [CI] 1.78 to 2.86), fatal/nonfatal myocardial infarction (HR 2.16, 95% CI 1.67 to 2.80), fatal/nonfatal stroke (HR 1.76, 95% CI 1.39 to 2.21), and the composite CV end point (HR 1.99, 95% CI 1.70 to 2.33). After further adjusting for standard CV risk factors, baseline blood pressure, and severity of ECG LVH, ECG strain remained a significant predictor of CV mortality (HR 1.53, 95% CI 1.18 to 2.00), myocardial infarction (HR 1.55, 95% CI 1.16 to 2.06), and the composite CV end point (HR 1.33, 95% CI 1.11 to 1.59). Thus, ECG strain is a marker of increased CV risk in hypertensive patients in the setting of aggressive blood pressure lowering, independent of baseline severity of ECG LVH.

Key Words: coronary disease • electrocardiography • hypertension

This article has been cited by other articles:

				P. M. Okin, L. Oikarinen, M. Viitasalo, L. Toivonen, S. E. Kjeldsen, M. S. Nieminen, J. M. Edelman, B. Dahlof, R. B. Devereux, and for the LIFE Study Investigators Prognostic Value of Changes in the Electrocardiographic Strain Pattern During Antihypertensive Treatment: The Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE) Circulation, April 14, 2009; 119(14): 1883 - 1891. [Abstract] [Full Text] [PDF]

				E. W. Hancock, B. J. Deal, D. M. Mirvis, P. Okin, P. Kligfield, and L. S. Gettes AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part V: Electrocardiogram Changes Associated With Cardiac Chamber Hypertrophy A Scientific Statement From the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society Endorsed by the International Society for Computerized Electrocardiology J. Am. Coll. Cardiol., March 17, 2009; 53(11): 992 - 1002. [Full Text] [PDF]

				E. W. Hancock, B. J. Deal, D. M. Mirvis, P. Okin, P. Kligfield, and L. S. Gettes AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part V: Electrocardiogram Changes Associated With Cardiac Chamber Hypertrophy: A Scientific Statement From the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: Endorsed by the International Society for Computerized Electrocardiology Circulation, March 17, 2009; 119(10): e251 - e261. [Full Text] [PDF]

				P. M. Okin, R. B. Devereux, K. E. Harris, S. Jern, S. E. Kjeldsen, L. H. Lindholm, B. Dahlof, and for the LIFE Study Investigators In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study Hypertension, November 1, 2007; 50(5): 984 - 990. [Abstract] [Full Text] [PDF]

				P. M. Okin, R. B. Devereux, K. E. Harris, S. Jern, S. E. Kjeldsen, S. Julius, J. M. Edelman, B. Dahlof, and for the LIFE Study Investigators Regression of Electrocardiographic Left Ventricular Hypertrophy Is Associated with Less Hospitalization for Heart Failure in Hypertensive Patients Ann Intern Med, September 4, 2007; 147(5): 311 - 319. [Abstract] [Full Text] [PDF]

				H. Mitsuhashi, H. Yatsuya, K. Tamakoshi, K. Matsushita, R. Otsuka, K. Wada, K. Sugiura, S. Takefuji, Y. Hotta, T. Kondo, et al. Adiponectin Level and Left Ventricular Hypertrophy in Japanese Men Hypertension, June 1, 2007; 49(6): 1448 - 1454. [Abstract] [Full Text] [PDF]

				G. Salles, C. Cardoso, A. R. Nogueira, K. Bloch, and E. Muxfeldt Importance of the Electrocardiographic Strain Pattern in Patients With Resistant Hypertension Hypertension, September 1, 2006; 48(3): 437 - 442. [Abstract] [Full Text] [PDF]

				P. M. Okin, R. B. Devereux, M. S. Nieminen, S. Jern, L. Oikarinen, M. Viitasalo, L. Toivonen, S. E. Kjeldsen, B. Dahlof, and for the LIFE Study Investigators Electrocardiographic Strain Pattern and Prediction of New-Onset Congestive Heart Failure in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study Circulation, January 3, 2006; 113(1): 67 - 73. [Abstract] [Full Text] [PDF]

				P. M. Okin, M. J. Roman, L. G. Best, E. T. Lee, J. M. Galloway, B. V. Howard, and R. B. Devereux C-Reactive Protein and Electrocardiographic ST-Segment Depression Additively Predict Mortality: The Strong Heart Study J. Am. Coll. Cardiol., June 7, 2005; 45(11): 1787 - 1793. [Abstract] [Full Text] [PDF]

				A. Delgado-Almeida, M. P. Schneider, R. E. Schmieder, R. H. Fagard, and on behalf of the Syst-Eur investigators Critical Value of the Electrocardiogram in LVH: From Predictive Index to Therapeutic Reassessment Hypertension, February 1, 2005; 45(2): e6 - e7. [Full Text] [PDF]